PDF herunterladen
Psychiatr Prax 2003; 30(4): 216-220
DOI: 10.1055/s-2003-39487
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Pharmakotherapie der Kleptomanie - Literaturübersicht

Pharmacological Treatment of Kleptomania - ReviewRalf  Kozian1 , Franz  G.  Otto1
  • 1Kantonale Psychiatrische Klinik Rheinau/ZH
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
27. Mai 2003 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

Die Kleptomanie wird entsprechend weit verbreiteter Klassifikationssysteme wie ICD-10 und DSM-IV zu den Impulskontrollstörungen gerechnet. Insbesondere unter Berücksichtigung der Komorbidität ergibt sich, dass die Kleptomanie zum Spektrum zwanghafter Störungen (obsessive-compulsive disorder-spectrum) und zum umfassenderen Spektrum affektiver Störungen assoziiert ist. Daraus leitet sich dann eine psychopharmakologische Interventionsmöglichkeit mit Antidepressiva oder stimmungsstabilisierenden Medikamenten ab, für welche keine Ergebnisse von Therapiestudien vorliegen, über deren erfolgreichen Einsatz jedoch kasuistische Mitteilungen gegeben wurden. Unter der Voraussetzung einer gestörten zentralen Serotonintransmission scheint sich dabei insbesondere der Einsatz von Serotoninwiederaufnahmehemmer (SSRI) zu bewähren. Eine Therapiealternative scheint jedoch in der Anwendung von Naltrexon zu bestehen.

Abstract

According to most diagnostic manuals such as ICD-10 and DSM-IV, kleptomania is classified as an impulse-control disorder. With regard to comorbidity, kleptomania is related to the obsessive- compulsive disorder spectrum and to the broarder spectrum of affective disorders. Accordingly a psychopharmalogical intervention with anti-depressant drugs or mood stabilizers may be possible, even though there are to date no known results from controlled therapy studies. Nevertheless the successful administration of such medication has been reported in several cases. Assuming a disturbed central serotonin reuptake, the use of selective serotonin reuptake inhibitors (SSRI) seems to be indicated. But also naltrexone could be of use in kleptomania.

Literatur

  • 1 Dannon P N. Kleptomania: an impulse control disorder?.  Int J Psych Clin Pract. 2002;  6 3-7
    PubMedGoogle Scholar
  • 2 Gertz H J, Müller U. Ein Fall von Kleptomanie.  Psychiat Prax. 2002;  29 101-103
    PubMedGoogle Scholar
  • 3 Goldman M J. Kleptomania: making sense of the nonsensical.  Am J Psychiatry. 1991;  148 986-996
    PubMedGoogle Scholar
  • 4 Goldman M J. Kleptomania: an overview.  Psychiatric Annals. 1992;  22 68-71
    PubMedGoogle Scholar
  • 5 Sarasalo E, Bergman B, Toth J. Personality traits and psychiatric and somatic morbidity among kleptomaniacs.  Acta Psychiatr Scand. 1996;  94 358-364
    PubMedGoogle Scholar
  • 6 Mc Elroy S, Pope H G, Hudson J I, Keck P E, White K L. Kleptomania: a report of 20 cases.  Am J Psychiatry. 1991;  148 652-657
    PubMedGoogle Scholar
  • 7 Mc Elroy S, Keck P E, Phillips K A. Kleptomania, compulsive buying and binge-eating disorder.  J Clin Psychiatry. 1995;  56 (suppl 4) 14-26
    PubMedGoogle Scholar
  • 8 Lejoyeux M, Mc Loughlin M, Adès J. Epidemiology of behavioral dependence: literature review and results of original studies.  Eur Psychiatry. 2000;  15 129-134
    CrossrefPubMedGoogle Scholar
  • 9 Mc Elroy S, Hudson J I, Pope H G, Keck P E. Kleptomania: clinical characteristics and associated psychopathology.  Psychological Medicine. 1991;  21 93-108
    PubMedGoogle Scholar
  • 10 Hudson J I, Pope H G. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology?.  Am J Psychiatry. 1990;  147 552-564
    PubMedGoogle Scholar
  • 11 Mc Elroy S, Hudson J I, Pope H G, Keck P E, Aizley H G. The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationship to other psychiatric disorders.  Am J Psychiatry. 1992;  149 318-327
    PubMedGoogle Scholar
  • 12 Mc Elroy S, Pope H G, Keck P E, Hudson J I, Phillips K A, Strakowski S M. Are impulse-control disorders related to bipolar disorder?.  Comprehensive Psychiatry. 1996;  37 (4) 229-240
    CrossrefPubMedGoogle Scholar
  • 13 Hollander E, Wong C M. Obsessive-compulsive spectrum disorders.  J Clin Psychiatry. 1995;  56 (suppl 4) 3-6
    PubMedGoogle Scholar
  • 14 Hollander E, Rosen J. Impulsivity.  Journal of Psychopharmacology. 2000;  14 (2) (suppl 1) 39-44
    PubMedGoogle Scholar
  • 15 Joseph R. Frontal lobe psychopathology: Mania, depression, confabulation, catatonia, perseveration, obsessive compulsions and schizophrenia.  Psychiatry. 1999;  62 138-172
    PubMedGoogle Scholar
  • 16 Kozian R. Kleptomanie bei Frontalhirnläsion.  Psychiat Prax. 2001;  28 98-99
    PubMedGoogle Scholar
  • 17 Gössling H W, Rosin J. Kleptomanie vor und nach einer spontanen Subarachnoidalblutung - Ein neuropsychodynamischer Fall.  Fortschr Neurol Psychiat. 1994;  62 164-168
    PubMedGoogle Scholar
  • 18 Khan K, Martin I CA. Kleptomania as a presenting feature of cortical atrophy.  Acta psychiat scand. 1977;  56 168-172
    PubMedGoogle Scholar
  • 19 Nyffeler T, Regard M. Kleptomania in a patient with a right frontolimbic lesion.  Neuropsychiatry Neuropsychol Behav Neurol. 2001;  14 73-76
    PubMedGoogle Scholar
  • 20 Evenden J. Impulsivity: a discussion of clinical and experimental findings.  J Psychopharmacol. 1999;  13 180-192
    PubMedGoogle Scholar
  • 21 Kim S W. Opioid antagonists in the treatment of impulse-control disorders.  J Clin Psychiatry. 1998;  59 159-164
    Google Scholar
  • 22 Volkow N D, Fowler J S, Wolf A P. et al . Changes in brain glucose metabolism in cocaine dependence and withdrawal.  Am J Psychiatry. 1991;  148 621-626
    PubMedGoogle Scholar
  • 23 Ho M Y, Al-Zahrani S SA, Al-Ruwaitea A SA, Bradshaw C M, Szabadi E. 5-Hydroxytryptamine and impulse control: prospects for a behavioural analysis.  Journal of Psychopharmacology. 1998;  12 (1) 68-78
    CrossrefPubMedGoogle Scholar
  • 24 Marazziti D, Dell'Osso L, Presta S, Pfanner C, Rossi A, Masala I. et al . Platelet [3H] paroxetine binding in patients with OCD-related disorders.  Psychiatry Research. 1999;  89 223-228
    CrossrefPubMedGoogle Scholar
  • 25 Grant J E, Kim S W. An open-label study of naltrexone in the treatment of kleptomania.  J Clin Psychiatry. 2002;  63 349-356
    CrossrefPubMedGoogle Scholar
  • 26 Durst R, Katz G, Teitelbaum A, Zislin J, Dannon P N. Kleptomania-diagnosis and treatment options.  CNS Drugs. 2001;  15 185-195
    PubMedGoogle Scholar
  • 27 Fishbain D A. Kleptomanic behavior response to perphenazine-amitriptylin hcl combination.  Canadian Journal of psychiatry. 1988;  33 (3) 241-242
    PubMedGoogle Scholar
  • 28 Mc Elroy S, Keck P E, Pope H G, Hudson J I. Pharmacological treatment of kleptomania and bulimia nervosa.  J Clin Psychopharmacol. 1989;  9 358-360
    PubMedGoogle Scholar
  • 29 Kraus J E. Treatment of kleptomania with paroxetine.  J Clin Psychiatry. 1999;  60 793
    PubMedGoogle Scholar
  • 30 Lepkifker E, Dannon P N, Reuven Z, Iancu I, Horesh N, Kotler M. The treatment of kleptomania with serotonin reuptake inhibitors.  Clinical Neuropharmacology. 1999;  22 40-43
    PubMedGoogle Scholar
  • 31 Chong S A, Low B L. Treatment of kleptomania with fluvoxamine.  Acta Psychiatr Scand. 1996;  93 314-315
    PubMedGoogle Scholar
  • 32 Burstein A. Fluoxetine-lithium treatment for kleptomania.  J Clin Psychiatry. 1992;  53 28-29
    PubMedGoogle Scholar
  • 33 Feeney D J, Klykylo W M. Treatment for kleptomania.  J Am Acad Child Adolesc Psychiatry. 1997;  36 723-724
    PubMedGoogle Scholar
  • 34 Durst R, Katz G, Knobler H Y. Buspirone augmentation of fluvoxamine in the treatment of kleptomania.  J Nerv Ment Dis. 1997;  185 586-588
    PubMedGoogle Scholar
  • 35 Kmetz G F, Mc Elroy S, Collins D J. Response of kleptomania and mixed mania to valproate.  Am J Psychiatry. 1997;  154 580-581
    PubMedGoogle Scholar
  • 36 Kindler S, Dannon P N, Iancu I, Sasson Y, Zohar J. Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors.  Clinical Neuropharmacology. 1997;  20 126-129
    PubMedGoogle Scholar
  • 37 Rocha F L, Rocha M E. Kleptomania, mood disorder and lithium.  Arq Neuropsiquiatr. 1992;  50 (4) 543-546
    PubMedGoogle Scholar
  • 38 Litten R Z, Allen J P. Medications for alcohol, illicit drug, and tobacco dependence.  J Subst Abuse Treatment. 1999;  16 105-112
    PubMedGoogle Scholar
  • 39 Dannon P N, Iancu I, Grunhaus L. Naltrexone treatment in kleptomanic patients.  Hum Psychopharmacol Clin Exp. 1999;  14 583-585
    CrossrefPubMedGoogle Scholar

Dr. Ralf Kozian

Landesklinik Brandenburg

Anton-Saefkow-Allee 2

14772 Brandenburg